Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 36,971 | 31,390 | 23,955 | 20,551 | 16,299 |
| Cost of Goods | 14,279 | 12,268 | 10,341 | 7,020 | 5,176 |
| Gross Profit | 22,692 | 19,122 | 13,614 | 13,531 | 11,123 |
| Operating Expenses | 47,135 | 39,124 | 36,401 | 29,883 | 24,673 |
| Operating Income | -24,164 | -19,734 | -22,446 | -16,332 | -13,374 |
| Interest Expense | 2,388 | 518 | 0 | 81 | 973 |
| Other Income | 1,067 | 1,350 | 357 | -22 | -63 |
| Pre-tax Income | -25,485 | -18,902 | -22,089 | -16,435 | -14,410 |
| Income Tax | 55 | 12 | N/A | N/A | N/A |
| Net Income Continuous | -25,540 | -18,914 | -22,089 | -16,435 | -14,410 |
| Net Income | $-25,540 | $-18,914 | $-22,089 | $-16,435 | $-14,410 |
| EPS Basic Total Ops | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 |
| EPS Basic Continuous Ops | -0.90 | -0.70 | -0.90 | -0.68 | -0.70 |
| EPS Diluted Total Ops | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 |
| EPS Diluted Continuous Ops | -0.90 | -0.70 | -0.90 | -0.68 | -0.70 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.70 | -0.90 | -0.68 | -0.69 |
| EBITDA(a) | $-21,844 | $-17,780 | $-20,932 | $-15,500 | $-12,582 |